AAAAAA
Results:
1-24
|
Results: 24
QUANTITATION AND BIOCHEMICAL-CHARACTERIZATION OF THE PLASMATIC FORM OF THE HUMAN SOLUBLE IL-5R-ALPHA
Authors:
MONTEROJULIAN FA
RAMANANARIVO T
TARTOUR E
BRAILLY H
Citation: Fa. Monterojulian et al., QUANTITATION AND BIOCHEMICAL-CHARACTERIZATION OF THE PLASMATIC FORM OF THE HUMAN SOLUBLE IL-5R-ALPHA, European cytokine network, 9(3), 1998, pp. 286-286
Authors:
MONTEROJULIAN FA
KALAI M
CONTENT J
WOLLMER A
BRAILLY H
GROTZINGER J
Citation: Fa. Monterojulian et al., MOLECULAR MODELING AND EXPLORATION OF THE SURFACE OF THE RHIL-6 DIMER- IMPLICATIONS FOR THE HIL-6 RECEPTOR COMPLEX ASSEMBLY, European cytokine network, 9(3), 1998, pp. 343-343
Authors:
JACQUES Y
MINVIELLE S
MULLERNEWEN G
HEINRICH PC
GROTZINGER J
MONTEROJULIAN F
BRAILLY H
WILKIN JM
CONTENT J
Citation: Y. Jacques et al., THE INTERLEUKIN-11 RECEPTOR COMPLEX - RATIONAL DESIGN OF AGONISTS/ANTAGONISTS AND IMMUNOASSAYS POTENTIALLY USEFUL IN HUMAN THERAPY/, Research in immunology (Paris), 149(7-8), 1998, pp. 737-740
Authors:
MONTEROJULIAN FA
BRAILLY H
SAUTES C
JOYEUX I
DORVAL T
MOSSERI V
YASUKAWA K
WIJDENES J
ADLER A
GORIN I
FRIDMAN WH
TARTOUR E
Citation: Fa. Monterojulian et al., CHARACTERIZATION OF SOLUBLE GP130 RELEASED BY MELANOMA CELL-LINES - APOLYVALENT ANTAGONIST OF CYTOKINES FROM THE INTERLEUKIN-6 FAMILY, Clinical cancer research, 3(8), 1997, pp. 1443-1451
Authors:
LEBEAU B
JULIAN FAM
WIJDENES J
MULLERNEWEN G
DAHMEN H
CHEREL M
HEINRICH PC
BRAILLY H
HALLET MM
GODARD A
MINVIELLE S
JACQUES Y
Citation: B. Lebeau et al., RECONSTITUTION OF 2 ISOFORMS OF THE HUMAN INTERLEUKIN-11 RECEPTOR ANDCOMPARISON OF THEIR FUNCTIONAL-PROPERTIES, FEBS letters, 407(2), 1997, pp. 141-147
Authors:
KALAI M
MONTEROJULIAN FA
BRAKENHOFF JPJ
FONTAINE V
DEWIT L
WOLLMER A
BRAILLY H
CONTENT J
GROTZINGER J
Citation: M. Kalai et al., ANALYSIS OF THE MECHANISM OF ACTION OF ANTI-HUMAN INTERLEUKIN-6 AND ANTI-HUMAN INTERLEUKIN-6 RECEPTOR-NEUTRALIZING MONOCLONAL-ANTIBODIES, European journal of biochemistry, 249(3), 1997, pp. 690-700
Authors:
KALAI M
MONTEROJULIAN FA
GROTZINGER J
FONTAINE V
VANDENBUSSCHE P
DESCHUYTENEER R
WOLLMER A
BRAILLY H
CONTENT J
Citation: M. Kalai et al., ANALYSIS OF THE HUMAN INTERLEUKIN-6 HUMAN INTERLEUKIN-6 RECEPTOR-BINDING INTERFACE AT THE AMINO-ACID LEVEL - PROPOSED MECHANISM OF INTERACTION, Blood, 89(4), 1997, pp. 1319-1333
Authors:
KALAI M
MONTEROJULIAN FA
GROTZINGER J
FONTAINE V
VANDENBUSSCHE P
DESCHUYTENEER R
WOLLMER A
BRAILLY H
CONTENT J
Citation: M. Kalai et al., THE IL-6 IL-6R BINDING INTERFACE - PROPOSED MECHANISM OF INTERACTION/, Archives of physiology and biochemistry, 104(3), 1996, pp. 43-43
Authors:
HAN DS
POTTINCLEMENCEAU C
IMRO MA
SCUDELETTI M
DOUCET C
PUPPO F
BROUTYBOYE D
VEDRENNE J
SAHRAOUI Y
BRAILLY H
POGGI A
JASMIN C
AZZARONE B
INDIVERI F
Citation: Ds. Han et al., IL2 TRIGGERS A TUMOR PROGRESSION PROCESS IN A MELANOMA CELL-LINE MELP, DERIVED FROM A PATIENT WHOSE METASTASIS INCREASED IN SIZE DURING IL2INF-ALPHA BIOTHERAPY/, Oncogene, 12(5), 1996, pp. 1015-1023
Authors:
KALAI M
MONTEROJULIAN FA
GROTZINGER J
WOLLMER A
MORELLE D
BROCHIER J
ROSEJOHN S
HEINRICH PC
BRAILLY H
CONTENT J
Citation: M. Kalai et al., PARTICIPATION OF 2 SER-SER-PHE-TYR REPEATS IN INTERLEUKIN-6 (IL-6)-BINDING SITES OF THE HUMAN IL-6 RECEPTOR, European journal of biochemistry, 238(3), 1996, pp. 714-723
Authors:
FRANCOIS C
SOREL M
CHEREL M
BRAILLY H
MINVIELLE S
BLANCHARD D
JACQUES Y
Citation: C. Francois et al., IMMUNOLOGICAL CHARACTERIZATION OF ANTIGENIC DOMAINS ON HUMAN IL-2 RECEPTOR-BETA SUBUNIT - EPITOPE-FUNCTION RELATIONSHIPS, International immunology, 7(8), 1995, pp. 1173-1181
Authors:
KLEIN B
BRAILLY H
Citation: B. Klein et H. Brailly, CYTOKINE-BINDING PROTEINS - STIMULATING ANTAGONISTS, Immunology today, 16(5), 1995, pp. 216-220
Authors:
LU ZY
BRAILLY H
WIJDENES J
BATAILLE R
ROSSI JF
KLEIN B
Citation: Zy. Lu et al., MEASUREMENT OF WHOLE-BODY INTERLEUKIN-6 (IL-6) PRODUCTION - PREDICTION OF THE EFFICACY OF ANTI-IL-6 TREATMENTS, Blood, 86(8), 1995, pp. 3123-3131
Authors:
MONTEROJULIAN FA
KLEIN B
GAUTHEROT E
BRAILLY H
Citation: Fa. Monterojulian et al., PHARMACOKINETIC STUDY OF ANTI-INTERLEUKIN-6 (IL-6) THERAPY WITH MONOCLONAL-ANTIBODIES - ENHANCEMENT OF IL-6 CLEARANCE BY COCKTAILS OF ANTI-IL-6 ANTIBODIES, Blood, 85(4), 1995, pp. 917-924
Authors:
LIAUTARD J
GAILLARD JP
MANI JC
MONTEROJULIAN F
DUPERRAY C
LU ZY
JOURDAN M
KLEIN B
BRAILLY H
BROCHIER J
Citation: J. Liautard et al., EPITOPE ANALYSIS OF HUMAN IL-6 RECEPTOR GP80 MOLECULE WITH MONOCLONAL-ANTIBODIES, European cytokine network, 5(3), 1994, pp. 293-300
Authors:
MONTEROJULIAN FA
GAUTHEROT E
WIJDENES J
KLEIN B
BRAILLY H
Citation: Fa. Monterojulian et al., PHARMACOKINETICS OF INTERLEUKIN-6 DURING THERAPY WITH ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODIES - ENHANCED CLEARANCE OF INTERLEUKIN-6 BY A COMBINATION OF 3 ANTI-INTERLEUKIN-6 ANTIBODIES, Journal of interferon research, 14(5), 1994, pp. 301-302
Authors:
MONTEROJULIAN FA
GAUTHEROT E
WIJDENES J
KLEIN B
BRAILLY H
Citation: Fa. Monterojulian et al., PHARMACOKINETICS OF INTERLEUKIN-6 DURING THERAPY WITH ANTI-INTERLEUKIN-6 MONOCLONAL-ANTIBODIES - ENHANCED CLEARANCE OF INTERLEUKIN-6 BY A COMBINATION OF 3 ANTI-INTERLEUKIN-6 ANTIBODIES, Journal of interferon research, 14(5), 1994, pp. 301-302
Authors:
MONTEROJULIAN FA
LIAUTARD J
FLAVETTA S
ROMAGNE F
GAILLARD JP
BROCHIER J
KLEIN B
BRAILLY H
Citation: Fa. Monterojulian et al., IMMUNOASSAY FOR FUNCTIONAL HUMAN SOLUBLE INTERLEUKIN-6 RECEPTOR IN PLASMA BASED ON LIGAND RECEPTOR INTERACTIONS/, Journal of immunological methods, 169(1), 1994, pp. 111-121
Authors:
BRAILLY H
MONTEROJULIAN FA
ZUBER CE
FLAVETTA S
GRASSI J
HOUSSIAU F
VANSNICK J
Citation: H. Brailly et al., TOTAL INTERLEUKIN-6 IN PLASMA MEASURED BY IMMUNOASSAY, Clinical chemistry, 40(1), 1994, pp. 116-123
Authors:
TARTOUR E
DORVAL T
MOSSERI V
DENEUX L
MATHIOT C
BRAILLY H
MONTERO F
JOYEUX I
POUILLART P
FRIDMAN WH
Citation: E. Tartour et al., SERUM INTERLEUKIN-6 AND C-REACTIVE PROTEIN-LEVELS CORRELATE WITH RESISTANCE TO IL-2 THERAPY AND POOR SURVIVAL IN MELANOMA PATIENTS, British Journal of Cancer, 69(5), 1994, pp. 911-913
Authors:
LU ZY
BRAILLY H
ROSSI JF
WIJDENES J
BATAILLE R
KLEIN B
Citation: Zy. Lu et al., OVERALL INTERLEUKIN-6 PRODUCTION EXCEEDS 7 MG DAY IN MULTIPLE-MYELOMACOMPLICATED BY SEPSIS/, Cytokine, 5(6), 1993, pp. 578-582
Authors:
BRAILLY H
PEBUSQUE MJ
TABILIO A
MANNONI P
Citation: H. Brailly et al., TNF-ALPHA ACTS IN SYNERGY WITH GM-CSF TO INDUCE PROLIFERATION OF ACUTE MYELOID-LEUKEMIA CELLS BY UP-REGULATING THE GM-CSF RECEPTOR AND GM-CSF GENE-EXPRESSION, Leukemia, 7(10), 1993, pp. 1557-1563
Authors:
HALFMANN G
BRAILLY H
BERNADAC A
MONTEROJULIAN FA
LAZDUNSKI C
BATY D
Citation: G. Halfmann et al., TARGETING OF INTERLEUKIN-2 TO THE PERIPLASM OF ESCHERICHIA-COLI, Journal of General Microbiology, 139, 1993, pp. 2465-2473
Authors:
COSTELLO R
BRAILLY H
MALLET F
MAWAS C
OLIVE D
Citation: R. Costello et al., INTERLEUKIN-7 IS A POTENT COSTIMULUS OF THE ADHESION PATHWAY INVOLVING CD2 AND CD28 MOLECULES, Immunology, 80(3), 1993, pp. 451-457
Risultati:
1-24
|